Valicenti Advisory Services Inc Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Valicenti Advisory Services Inc

$389 Million
Q3 2024

A detailed history of Valicenti Advisory Services Inc transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Valicenti Advisory Services Inc holds 34,995 shares of PPH stock, worth $3.03 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

34,995

Previous 35,060 0.19%

Holding current value

$3.03 Million

Previous $3.21 Million 3.71%

% of portfolio

0.85%

Previous 0.86%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$90.59 - $99.43 $5,888 - $6,462	-65 Reduced 0.19%	34,995 $3.33 Million
Q2 2024 Jul 23, 2024	BUY	$84.87 - $93.23 $1.5 Million - $1.65 Million	17,655 Added 101.44%	35,060 $3.21 Million
Q1 2024 Apr 23, 2024	SELL	$82.63 - $90.89 $4.68 Million - $5.15 Million	-56,686 Reduced 76.51%	17,405 $1.58 Million
Q4 2023 Jan 16, 2024	SELL	$74.32 - $81.37 $403,037 - $441,269	-5,423 Reduced 6.82%	74,091 $6.03 Million
Q3 2023 Oct 18, 2023	BUY	$76.26 - $83.18 $253,106 - $276,074	3,319 Added 4.36%	79,514 $6.35 Million
Q2 2023 Jul 12, 2023	SELL	$75.02 - $80.55 $376,600 - $404,361	-5,020 Reduced 6.18%	76,195 $6 Million
Q1 2023 Apr 20, 2023	BUY	$73.68 - $79.63 $684,118 - $739,364	9,285 Added 12.91%	81,215 $6.31 Million
Q4 2022 Jan 17, 2023	BUY	$67.31 - $79.26 $4.84 Million - $5.7 Million	71,930 New	71,930 $5.59 Million

Others Institutions Holding PPH

# of Institutions

146

Shares Held

5.83M

Call Options Held

12.6K

Put Options Held

7.3K

View Full List

About VANECK ETF TR VANECK PHARMACEU

Ticker PPH
Sector ETFs
Industry ETFs

More about PPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valicenti Advisory Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valicenti Advisory Services Inc with notifications on news.

Account

Valicenti Advisory Services Inc Vaneck ETF Tr Vaneck Pharmaceu Transaction History